Overview

Defibrillators Market is poised to value over CAGR of over 3.1% during the forecast period 2022 to 2028.

The primary factors driving the growth of the market are the increased occurance of target diseases, rising emphasis on providing public access defibrillators and creation of awareness pertaining to the usage of defibrillators.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Defibrillators Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Defibrillators Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Defibrillators Market:
• Medtronic
• St. Jude Medical LLC
• Boston Scientific Corporation
• Physio-Control Inc.
• LivaNova
• MS Westfalia GmbH
• Koninklijke Philips N.V.
• Schiller AG
• ZOLL Medical Corporation
• Cardiac Science
• Nihon Kohden Corporation
• Defibtech LLC
• Progetti Srl
• AMI Italia, Ltd.
• Biotronik
• CU Medical Systems
• Mediana
• Metsis Medikal
• Microport
• Mindray Medical

(Note: The list of the major players will be updated with the latest market scenario and trends)

Defibrillators Market Segmentation:

By Type

• Implantable Cardioverter Defibrillators (ICDs)
    o Transvenous Implantable Cardioverter Defibrillators
    o Subcutaneous Implantable Cardioverter Defibrillators
• External Defibrillators
    o Manual & Semi-Automated External Defibrillators
    o Fully Automated External Defibrillators
    o Wearable Cardioverter Defibrillators

By End User

• Hospitals, Clinics, and Cardiac Centers
• Prehospital Care Settings
• Public Access Markets
• Home Care Settings
• Alternate Care Facilities

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Defibrillators Market By Type, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
       1.1 Objectives of the Study 
       1.2 Market Definition 
       1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered
       1.4 Currency 
       1.5 Limitations 
       1.6 Stakeholders 

 2.  Research Methodology 
       2.1 Research Data 
              2.1.1 Secondary Data
                 2.1.1.1 Key Data from Secondary Sources
              2.1.2 Primary Data
                 2.1.2.1 Key Data from Primary Sources
       2.2 Market Size Estimation 
       2.3 Market Breakdown and Data Triangulation 
       2.4 Assumptions for the Study  

3. Executive Summary
       3.1 Market Outlook
       3.2 Segment Outlook
       3.3 Competitive Insights

4. Global Defibrillators Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances

5. Market Overview
       5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Defibrillators Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Defibrillators Market Analysis Tools
       6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
       6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
       6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
       6.4. Market Entry Strategies
       6.5. Case Studies

7. Global Defibrillators Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)
       7.1. Implantable Cardioverter Defibrillators (ICDs)
              7.1.1. Transvenous Implantable Cardioverter Defibrillators
              7.1.2. Subcutaneous Implantable Cardioverter Defibrillators
       7.2. External Defibrillators
              7.2.1. Manual & Semi-Automated External Defibrillators
              7.2.2. Fully Automated External Defibrillators
              7.2.3. Wearable Cardioverter Defibrillators

8. Global Defibrillators Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
       8.1. Hospitals, Clinics, and Cardiac Centers
       8.2. Prehospital Care Settings
       8.3. Public Access Markets
       8.4. Home Care Settings
       8.5. Alternate Care Facilities

9.  North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       9.1. Introduction
       9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
            9.2.1. U.S.A
            9.2.2. Canada
            9.2.3. Mexico
       9.3. Market Size (USD Million) Forecast for North America 2022-2028

10. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       10.1. Introduction
       10.2. Regional Market Trends
       10.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020
            10.3.1. Brazil
            10.3.2. Venezuela
            10.3.3. Argentina
            10.3.4. Rest of Latin America
       10.4. Market Size (USD Million) Forecast for Latin America 2022-2028

11. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       11.1. Introduction
       11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
            11.2.1. Germany
            11.2.2. U.K
            11.2.3. France
            11.2.4. Italy
            11.2.5. Spain
            11.2.6. Russia
            11.2.7. Poland
            11.2.8. Switzerland
            11.2.9. Rest of Western Europe

12. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       12.1. Introduction
       12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
             12.2.1. Japan
             12.2.2. China
             12.2.3. Singapore
             12.2.4. India
             12.2.5. Australia and New Zealand
             12.2.6. ASEAN
             12.2.7. South Korea
             12.2.8. Rest of Asia Pacific
       12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028

13. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
       13.1. Introduction
       13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
             13.2.1. GCC
             13.2.2. Israel
             13.2.3. South Africa
             13.2.4. Rest of MEA
       13.3. Market Size (USD Million) Forecast for MEA 2022-2028

14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts)
        14.1. Medtronic
                14.1.1. Company Overview
                14.1.2. Product Portfolio
                14.1.3. SWOT Analysis
                14.1.4. Financial Overview
                14.1.5. Strategic Overview
        14.2. St. Jude Medical LLC
                14.2.1. Company Overview
                14.2.2. Product Portfolio
                14.2.3. SWOT Analysis
                14.2.4. Financial Overview
                14.2.5. Strategic Overview
        14.3. Boston Scientific Corporation
                14.3.1. Company Overview
                14.3.2. Product Portfolio
                14.3.3. SWOT Analysis
                14.3.4. Financial Overview
                14.3.5. Strategic Overview
        14.4. Physio-Control Inc.
                14.4.1. Company Overview
                14.4.2. Product Portfolio
                14.4.3. SWOT Analysis
                14.4.4. Financial Overview
                14.4.5. Strategic Overview
        14.5. LivaNova
                14.5.1. Company Overview
                14.5.2. Product Portfolio
                14.5.3. SWOT Analysis
                14.5.4. Financial Overview
                14.5.5. Strategic Overview
         14.6. MS Westfalia GmbH
                14.6.1. Company Overview
                14.6.2. Product Portfolio
                14.6.3. SWOT Analysis
                14.6.4. Financial Overview
                14.6.5. Strategic Overview
        14.7. Koninklijke Philips N.V
                14.7.1. Company Overview
                14.7.2. Product Portfolio
                14.7.3. SWOT Analysis
                14.7.4. Financial Overview
                14.7.5. Strategic Overview
        14.8. Schiller AG
                14.8.1. Company Overview
                14.8.2. Product Portfolio
                14.8.3. SWOT Analysis
                14.8.4. Financial Overview
                14.8.5. Strategic Overview
        14.9. ZOLL Medical Corporation
                14.9.1. Company Overview
                14.9.2. Product Portfolio
                14.9.3. SWOT Analysis
                14.9.4. Financial Overview
                14.9.5. Strategic Overview
       14.10. Cardiac Science
                14.10.1. Company Overview
                14.10.2. Product Portfolio
                14.10.3. SWOT Analysis
                14.10.4. Financial Overview
                14.10.5. Strategic Overview
       14.11. Nihon Kohden Corporation
                14.11.1. Company Overview
                14.11.2. Product Portfolio
                14.11.3. SWOT Analysis
                14.11.4. Financial Overview
                14.11.5. Strategic Overview
       14.12. Defibtech LLC
                14.12.1. Company Overview
                14.12.2. Product Portfolio
                14.12.3. SWOT Analysis
                14.12.4. Financial Overview
                14.12.5. Strategic Overview
       14.13. Progetti Srl
                14.13.1. Company Overview
                14.13.2. Product Portfolio
                14.13.3. SWOT Analysis
                14.13.4. Financial Overview
                14.13.5. Strategic Overview
       14.14. AMI Italia, Ltd.
                14.14.1. Company Overview
                14.14.2. Product Portfolio
                14.14.3. SWOT Analysis
                14.14.4. Financial Overview
                14.14.5. Strategic Overview
       14.15. Biotronik
                14.15.1. Company Overview
                14.15.2. Product Portfolio
                14.15.3. SWOT Analysis
                14.15.4. Financial Overview
                14.15.5. Strategic Overview
       14.16. CU Medical Systems
                14.16.1. Company Overview
                14.16.2. Product Portfolio
                14.16.3. SWOT Analysis
                14.16.4. Financial Overview
                14.16.5. Strategic Overview
       14.17. Mediana
                14.17.1. Company Overview
                14.17.2. Product Portfolio
                14.17.3. SWOT Analysis
                14.17.4. Financial Overview
                14.17.5. Strategic Overview
      14.18. Metsis Medikal
                14.18.1. Company Overview
                14.18.2. Product Portfolio
                14.18.3. SWOT Analysis
                14.18.4. Financial Overview
                14.18.5. Strategic Overview
       14.19. Microport
                14.19.1. Company Overview
                14.19.2. Product Portfolio
                14.19.3. SWOT Analysis
                14.19.4. Financial Overview
                14.19.5. Strategic Overview
       14.20. Mindray Medical
                14.20.1. Company Overview
                14.20.2. Product Portfolio
                14.20.3. SWOT Analysis
                14.20.4. Financial Overview
                14.20.5. Strategic Overview
15. Pre and Post COVID-19 Impact
    15.1. Positive influence on the healthcare industry
    15.2. The financial disruption of the manufacturing sector
    15.3. Impact of COVID-19 on emerging companies
    15.4. Significant mandates in the healthcare regulations initiated by administrations
    15.5. The overall economic slowdown of the developing and developed nations       
16. FutureWise SME key takeaway points for Client

Tables

Figures